Microbiome revolution

Understanding the Microbiome

At YSOPIA Bioscience, we strongly believe that the gut microbiome – as it plays a crucial role in human health – is the next paradigm-shift in medicine and a tremendous hope for patients.

“The composition of the microbiome and its activities are involved in most, if not all, of the biological processes that constitute human health and disease.” M. J. Blaser in J. Clin. Invest. (2014). 

Microbiome is a “hidden organ” which controls our health. Bacteria shape their host and are precious partners, playing a central role in a myriad of essential functions in our body – such as metabolism, digestion, immune and neurological functions – through different pathways.

Our gut microbiome is like a virgin forest: a complex and diverse ecosystem which functions in symbiosis with our body. Our modern life, characterized by unhealthy diet, pollution, stress and chemical exposure, can strongly deteriorate this symbiosis. 

> Discover our pipeline

At the Root of Chronic Diseases

Countless studies have recently established the strong links between a disbalance of the microbiome and the development of chronic diseases. In this context, the best way to target the root causes of the disease is by treating this disbalance.

In today’s world, one in three adults suffer from multiple chronic conditions. There is an urgent need to better address chronic diseases.

Chronic diseases are complex and result from a combination of genetic, physiological, environmental and behavioural factors. Despite their complexity, they all share one common feature: an imbalance of microbiome, called dysbiosis, scientifically established as a cause of these diseases.

 

Microbiome & us
News
Apr 8, 2022
YSOPIA Bioscience Announces the Appointment of Dr. Jean-Pierre Lehner as New Chairman of the Board of Directors |...
> more
Apr 8, 2022
YSOPIA Bioscience annonce la nomination du Dr. Jean-Pierre Lehner comme nouveau Président du Conseil d’Administration...
> more
Press / Media
Apr 14, 2022
     Fabrice Guez, CEO et CFO d’Ysopia Bioscience Observation au microscope de la morphologie de bactéries...
> more
Mar 15, 2022
Le fonds Health for Life Capital II™ et les sociétés de son portefeuille ont connu une année 2021 exceptionnelle....
> more
Publications
Apr 11, 2022
Karima Relizani, Katy Le Corf, Camille Kropp, Rebeca Martin-Rosique, Déborah Kissi, Guillaume Déjean, Lisa...
> more
Feb 16, 2022
Samuel Bellais, Mélanie Nehlich, Maryne Ania, Aurore Duquenoy, Wilfrid Mazier, Ger van den Engh, Jan Baijer, Nicole...
> more
now on twitter
YSOPIA Bioscience

Antimicrobial resistant bacteria are present in newborns after just a few hours of life and they help to understand… t.co/jkL4ih4dFA

YSOPIA Bioscience © 2022 - all rights reserved terms and conditions